Bristol Myers cuts profit target despite new-drug momentum
Reuters reports that new medicines are boosting Bristol Myers, but the company has lowered its profit target.
Related stories
Caterpillar Reports Net Profit in Q3
M impact | EARNINGS | Oct 29, 2026, 04:42 PM UTC
Bunge Reports Higher Third-Quarter Net Income
Bunge reported higher net income in the third quarter.
L impact | EARNINGS | Oct 29, 2026, 04:42 PM UTC
Smithfield’s Third-Quarter Profit Falls; Cuts 2026 Outlook
Smithfield reported a decline in third-quarter profit and reduced its projections for 2026.
M impact | EARNINGS | Oct 29, 2026, 04:41 PM UTC
BorgWarner Reports 2026 Revenue of $3.49B and EPS of $1.08
Revenue fell 2.9% from the prior-year period, while net income rose 39.9% to $221 million and diluted EPS increased 47.9% to $1.08.
M impact | EARNINGS | Oct 29, 2026, 04:41 PM UTC
Pharma Mar reports nine-month revenue of €146.9 million
M impact | EARNINGS | Oct 29, 2026, 04:41 PM UTC
BUA Cement Reports Naira 357.79 Billion Revenue, Naira 172.27 Billion PBT
BUA Cement reported revenue of 357.79 billion naira and profit before tax of 172.27 billion naira for the three months ended September 30.
M impact | EARNINGS | Oct 29, 2026, 04:41 PM UTC